Companies: 10,795·Total market cap: $144.5T
Daiichi Sankyo Company, Limited

Daiichi Sankyo Company, Limited

DSKYFOTCHealthcare● Active
$16.20
+$0.92(+6.00%)
Market Cap$29.5B
P/E Ratio
52W High$29.15
52W Low$14.9

Daiichi Sankyo Company, Limited (DSKYF) Shares Outstanding — Overview

Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.

DSKYF · shares outstanding · updated Jun 10, 2026

Key metrics

Basic Shares Outstanding · Weighted average · fiscal year
1.850B -2.43% YoY Change
FY · as of Mar 31, 2026 · Reported in JPY
vs 1.896B in FY 2025
Diluted Shares Outstanding
1.851B
incl. options, RSUs, convertibles
Dilution Spread
+0.05%
Diluted vs Basic
YoY Change
-2.43%
year-over-year
Source: FMP /income-statement · /shares-float · SEC 10-K / 10-QUpdated: 2026-06-10

Shares Outstanding Growth Rate

3-Year CAGRdeclining
-1.2%
2023 → 2026
5-Year CAGRdeclining
-0.9%
2021 → 2026
10-Year CAGRdeclining
-1.1%
2016 → 2026

Negative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials

Shares outstanding history

↓ Decrease — typically buyback / retirement
↑ Increase — issuance / equity compensation
Latest
* most recent reported · FMP /income-statement · weightedAverageShsOut

Annual shares outstanding by year

FY 2026Latest
Diluted Shares: 1.851B
1.850B
-2.43%
FY 2025
Diluted Shares: 1.897B
1.896B
-1.09%
FY 2024
Diluted Shares: 1.919B
1.917B
+0.02%
FY 2023
Diluted Shares: 1.919B
1.917B
+0.02%
FY 2022
Diluted Shares: 1.918B
1.917B
-1.17%
FMP /income-statement · weightedAverageShsOut · weightedAverageShsOutDilUnit: Billions (B)

Healthcare sector shares outstanding comparison

Shares Outstanding for similar companies or competitors in the Healthcare sector.

#SymbolCompanyShares (Basic)vs DSKYF
#1
Merck & Co., Inc.MRK
Merck & Co., Inc.
2.502B+35.2%
#2
Johnson & JohnsonJNJ
Johnson & Johnson
2.429B+31.2%
#3
Daiichi Sankyo Company, LimitedDSKYF
Daiichi Sankyo Company, LimitedYOU
1.850B
#4
AbbVie Inc.ABBV
AbbVie Inc.
1.780B-3.8%
#5
AstraZeneca PLCAZN
AstraZeneca PLC
1.550B-16.2%
#6
UnitedHealth Group IncorporatedUNH
UnitedHealth Group Incorporated
910.0M-50.8%
#7
Eli Lilly and CompanyLLY
Eli Lilly and Company
898.0M-51.5%

/company-screener · per-peer /income-statement · cache 86400s

Understanding Shares Outstanding

What Are Shares Outstanding? (Basic)

Daiichi Sankyo Company, Limited (DSKYF) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of March 31, 2026, Daiichi Sankyo Company, Limited reports 1.850B basic shares outstanding (weighted average).

Basic vs. Diluted Shares Outstanding

Daiichi Sankyo Company, Limited's basic shares outstanding (1.850B) represents currently issued shares. Diluted shares outstanding (1.851B) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +0.05%.

Shares Outstanding vs. Float (Free Float)

Daiichi Sankyo Company, Limited's float is — (— of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.

Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.

FMP /income-statement · /shares-float · SEC EDGAR · JPY

About shares outstanding & methodology

Daiichi Sankyo Company, Limited (DSKYF) shares outstanding history from 2007 to 2026. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.

Daiichi Sankyo Company, Limited shares outstanding for the fiscal year ending March 31, 2026 were 1.850B, a 2.43% decline year-over-year. Daiichi Sankyo Company, Limited FY 2026 shares outstanding were 1.850B, a -2.43% decline from FY 2025.

Daiichi Sankyo Company, Limited is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of -1.1% — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.

Figures tie to SEC 10-K/10-Q income statement disclosures and FMP /income-statement · /shares-float where noted.

Frequently asked questions

DSKYF shares outstanding · 4 questions

As of March 31, 2026, Daiichi Sankyo Company, Limited (DSKYF) has approximately 1.850B basic shares outstanding and 1.851B diluted shares outstanding. This represents a -2.43% year-over-year change from FY 2025 (1.896B). Daiichi Sankyo Company, Limited's declining share count is primarily driven by its share buyback program. For the complete historical data table, see the history table above.

DSKYF shares outstandinghow many shares does DSKYF haveDSKYF basic shares 2026DSKYF diluted shares

Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · Daiichi Sankyo Company, Limited SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-10